Literature DB >> 12874070

Intratumoral lymphatics and lymph node metastases in papillary thyroid carcinoma.

Francis T Hall1, Jeremy L Freeman, Sylvia L Asa, David G Jackson, Nigel J Beasley.   

Abstract

OBJECTIVE: To examine the relationship between lymphatic vessel density and clinical and pathological variables in patients with well-differentiated papillary thyroid carcinoma.
SUBJECTS: Clinical information was retrieved on 109 previously untreated patients with well-differentiated papillary thyroid carcinoma treated with total thyroidectomy and postoperative iodine I 131 ablation. Median follow-up was 38 months.
DESIGN: Archived tissue specimens were sectioned and stained with hematoxylin-eosin and anti-LYVE-1 antibody, a highly specific marker for lymphatic endothelium. The size of the tumor and its multifocality were noted and lymphatic vessel density was measured by means of Chalkley point counting.
RESULTS: Numerous intratumoral lymphatics were seen in papillary thyroid carcinoma. There was a highly significant association between the presence of intratumoral lymphatics and the presence of neck node metastases (P<.001). There was also a significant association with male sex (P =.03) and the presence of multifocal disease (P =.05). The presence of intratumoral lymphatics remained significantly associated with the presence of nodal metastases at presentation (P =.003) on multivariate analysis. Intratumoral lymphatics were not a significant predictor of tumor recurrence (P =.42, log-rank test).
CONCLUSIONS: The development of intratumoral lymphatics in well-differentiated papillary thyroid carcinoma appears to be associated with the spread of tumor to regional lymph nodes. The antimetastatic potential of targeting these lymphatics may be of potential therapeutic benefit in the future.

Entities:  

Mesh:

Year:  2003        PMID: 12874070     DOI: 10.1001/archotol.129.7.716

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  29 in total

1.  Neoadjuvant Locoregional Therapy and Recurrent Hepatocellular Carcinoma after Liver Transplantation.

Authors:  Min Xu; Mb Majella Doyle; Babak Banan; Neeta Vachharajani; Xuanchuan Wang; Nael Saad; Kathryn Fowler; Elizabeth M Brunt; Yiing Lin; William C Chapman
Journal:  J Am Coll Surg       Date:  2017-04-09       Impact factor: 6.113

2.  Tumor cell transendothelial passage in the absorbing lymphatic vessel of transgenic adenocarcinoma mouse prostate.

Authors:  Giacomo Azzali
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

3.  Increased expression of pro-angiogenic factors and vascularization in thyroid hyperfunctioning adenomas with and without TSH receptor activating mutations.

Authors:  Marilena Celano; Marialuisa Sponziello; Giovanni Tallini; Valentina Maggisano; Rocco Bruno; Mariavittoria Dima; Enrico Di Oto; Adriano Redler; Cosimo Durante; Rosario Sacco; Sebastiano Filetti; Diego Russo
Journal:  Endocrine       Date:  2012-07-20       Impact factor: 3.633

4.  BRAFV600E Mutation: Has It a Role in Cervical Lymph Node Metastasis of Papillary Thyroid Cancer?

Authors:  Neslihan Kurtulmus; Burak Ertas; Yesim Saglican; Hakan Kaya; Umit Ince; Mete Duren
Journal:  Eur Thyroid J       Date:  2016-08-20

5.  Posterosuperior lesion has a high risk of lateral and central nodal metastasis in solitary papillary thyroid cancer.

Authors:  Dong Jin Lee; Kyu Ho Lee; Jin Hwan Kim; Kee Hwan Kwon; Dae Young Yoon; Young Soo Rho
Journal:  World J Surg       Date:  2015-02       Impact factor: 3.352

6.  Intratumoural lymph vessel density is related to presence of lymph node metastases and separates encapsulated from infiltrative papillary thyroid carcinoma.

Authors:  C Eloy; J Santos; P Soares; M Sobrinho-Simões
Journal:  Virchows Arch       Date:  2011-11-12       Impact factor: 4.064

7.  Lymph Node Metastases in Papillary and Medullary Thyroid Carcinoma Are Independent of Intratumoral Lymphatic Vessel Density.

Authors:  Filipe Pereira; Sofia S Pereira; Marta Mesquita; Tiago Morais; Madalena M Costa; Pedro Quelhas; Carlos Lopes; Mariana P Monteiro; Valeriano Leite
Journal:  Eur Thyroid J       Date:  2017-03-17

8.  High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma.

Authors:  Yun-Fei Xu; Fu-Jun Ge; Bo Han; Xiao-Qing Yang; Hong Su; An-Cheng Zhao; Ming-Hong Zhao; Yu-Bao Yang; Jie Yang
Journal:  World J Gastroenterol       Date:  2015-03-21       Impact factor: 5.742

9.  Lymph node metastases do not impact survival in follicular variant papillary thyroid cancer.

Authors:  David F Schneider; Dawn Elfenbein; Ricardo V Lloyd; Herbert Chen; Rebecca S Sippel
Journal:  Ann Surg Oncol       Date:  2014-08-05       Impact factor: 5.344

10.  Different significance between intratumoral and peritumoral lymphatic vessel density in gastric cancer: a retrospective study of 123 cases.

Authors:  Xiao-Lei Wang; Jian-Ping Fang; Ru-Yong Tang; Xi-Mei Chen
Journal:  BMC Cancer       Date:  2010-06-17       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.